# Armstrong World Industries Inc. (AWI) — Financial Analysis

**Exchange:** NYSE  
**Coverage as of:** 2026-Q2  
**Updated:** 2026-05-28  
**Tier:** Free primer (step 2 of 19)  
**Sibling pages:** /stocks/AWI/thesis · /stocks/AWI/memo

## Financial Snapshot

---
source: coverage-next-full
ticker: AWI
step: 04
type: financial_quality
date: 2026-05-28
---

### Step 04 — Financial Quality & Adversarial Sweep

#### Key Findings

- **No material adversarial findings.** No active SEC enforcement, no short-seller report, no notable litigation outside the legacy asbestos PI Trust (which is operationally separated from AWI and contractually capped), no restatement history, no material weakness in ICFR [S1][S2][S3].
- Quality-of-earnings (QoE) clean: cash conversion (CFO / Net income FY25 = $355.5M / $308.7M = 115%) is solidly above 100%, supporting the integrity of reported net income [S4].
- Adj. EBITDA is closely defined and reconciles to GAAP operating income + D&A + WAVE equity earnings + restructuring/special items (small) — no aggressive add-back culture [S1][S5].
- Working capital management is disciplined: receivables days ~52, inventory days ~85, payables days ~50 — stable, consistent with industry norm [S4].
- Step is **net positive** for thesis: financial reporting is clean and conservative, working capital is well-managed, no red flags found.

#### Implications for Thesis and Valuation

- Earnings quality supports applying a market multiple — no QoE discount needed [S4][S5].
- The legacy asbestos PI Trust is structurally separate (1998 Settlement Trust, AWI emerged from Chapter 11 in 2006 with capped residual obligation); does not warrant a contingency reserve adjustment in DCF [S2][S6].
- Pension is frozen (US qualified plan), pension expense is de-risked, and overfunded historically — not a balance-sheet risk [S1].
- WAVE equity earnings deserve careful treatment in EBITDA definitions; consensus and mgmt definitions both include them, so the financial-model build should follow suit [S1][S5].

#### Objective

Test the integrity of reported financials. Look for accounting aggressiveness, restatement risk, regulatory enforcement, litigation, short-seller activity, and any disclosure that would force a quality discount on the multiple.

#### Narrative Analysis

The starting point for QoE analysis at AWI is the cash-conversion record. FY25 net income was $308.7M and operating cash flow was $355.5M — a 115% conversion ratio. Looking back, this ratio has been consistently >100% in 4 of the last 6 fiscal years (FY20, FY23, FY24, FY25); the exceptions were FY21 (~102%) and FY22 (~90%, working capital build) [S4]. A multi-year average above 100% is strong evidence of conservative accruals and clean revenue recognition. Combined with a stable receivables-days metric (~52, vs. ~50 industry norm) and no working-capital "stretching" of payables, the QoE picture is clean [S4][S1].

The adversarial sweep covers six categories:

1. **SEC enforcement / accounting investigations.** No active investigation. AWI's most recent 10-K (2026-02-24) discloses no material weaknesses in internal controls, no pending SEC inquiries, and no restatement of historical financials. The PWC audit opinion is clean [S1]. Historical context: there is no record of an SEC enforcement action against post-2006 AWI (the post-Chapter-11 entity).

2. **Short-seller reports.** No notable short-seller activity in the last 24 months. AWI does not appear on prominent short-seller "to-watch" lists (Muddy Waters, Hindenburg, Spruce Point, etc.). Standard short-interest reporting shows AWI in the 1-3% range of float — modest and stable, no abnormal accumulation [S7]. The lack of bear activism is itself evidence of clean financials; a 0.5x net debt / ~30% ROIC building products name with the asbestos history would be a natural target if there were material concerns.

3. **Litigation.** The legacy asbestos PI Trust is the main residual litigation exposure. AWI established the trust as part of its 2006 Chapter 11 emergence, funded it via cash contributions + equity (the trust owned a majority stake at emergence), and capped its residual contractual obligation. The trust has since materially divested its AWI shares and is no longer a controlling shareholder [S2][S6]. The 10-K discloses no other material litigation beyond ordinary-course commercial disputes [S1]. No environmental Superfund site disclosures of consequence.

4. **Pension exposure.** AWI runs a frozen US qualified defined-benefit pension plan. Frozen means no further benefit accrual — only legacy obligations. The plan has historically been overfunded (per 10-K Note disclosures). AWI has executed settlement actions in prior years to de-risk further. Pension expense is small and not volatile [S1]. Pension is not a balance-sheet or income-statement risk.

5. **One-time / restructuring items.** Adj. EBITDA add-backs in FY25 are modest: ~$10-15M of acquisition-related expenses (3form / Zahner integration), small restructuring, and stock-based comp ($21.9M) [S1][S4]. SBC is the largest add-back at ~1.4% of revenue — modest by industrials standards but trending higher. No "kitchen-sink" charges, no goodwill impairments, no asset write-downs.

6. **Accounting policy red flags.** Revenue recognition is point-in-time on shipment for mineral fiber (standard); over-time recognition where appropriate for Architectural Specialties project work (also standard). No aggressive bill-and-hold, no channel stuffing inferences from inventory-days movement. Receivables aging is healthy. No related-party transactions of concern. PWC is the auditor (long tenure, no material disagreements disclosed). Useful lives for D&A are conservative (10-15 yrs for machinery, 30-40 yrs for buildings) [S1].

The WAVE JV equity earnings treatment deserves explicit note. AWI's adj. EBITDA definition includes its 50% share of WAVE's net earnings — typically $40-60M/yr. This is a non-cash addition to EBITDA at the JV level (cash distribution comes via WAVE dividends, ~$50-70M/yr to AWI's parent). The treatment is consistent with mgmt's presentation and Street consensus convention [S5][S1]. For DCF purposes (Step 13-14 in `/complete-coverage`), WAVE should be modeled as a recurring contributor — not as a one-time item — given the 25+ year track record of consistent earnings flow [S5].

#### Evidence and Sources

| Source | Document | Key Fact |
|--------|----------|----------|
| [S1] | 10-K FY2025 | Auditor opinion, controls, risk factors, litigation |
| [S2] | Wikipedia + Mesothelioma.net | Chapter 11 + trust history |
| [S3] | Short Interest reporting (NYSE) | Float concentration |
| [S4] | XBRL annual + Q financials | Cash conversion, WC trends |
| [S5] | 8-K Q1 2026 + 10-K disclosures | EBITDA definition |
| [S6] | EU CB review Knauf 2018 | EMEA divestiture |
| [S7] | Fintel + S&P Capital IQ | Short interest |

#### Assumption Register Updates

A24 (QoE quality factor: NEUTRAL — no premium, no discount) added. Affects multiple-selection in Step 14 valuation.

#### Tables and Calculations

##### Cash Conversion Multi-Year

| Year | Net Income ($M) | CFO ($M) | Conversion |
|------|----------------|----------|------------|
| FY20 | -99.1 (recon: -41 ex impairment) | 218.8 | n/a (loss year) |
| FY21 | 183.2 | 187.2 | 102% |
| FY22 | 202.9 | 182.4 | 90% (WC build) |
| FY23 | 223.8 | 233.5 | 104% |
| FY24 | 264.9 | 266.8 | 101% |
| FY25 | 308.7 | 355.5 | 115% |

5-year ex-FY20 avg: ~102%. Consistent with clean accruals.

##### Working Capital Days

| Year | DSO | DIO | DPO | CCC |
|------|-----|-----|-----|-----|
| FY23 | ~50 | ~80 | ~48 | ~82 |
| FY24 | ~52 | ~85 | ~50 | ~87 |
| FY25 | ~52 | ~85 | ~50 | ~87 |

Stable working capital. No deterioration.

##### Adversarial Sweep Result

| Category | Risk Score (1 low / 5 high) | Notes |
|----------|------------------------------|-------|
| SEC enforcement | 1 | None active or recent |
| Short-seller activity | 1 | No notable short campaigns |
| Litigation | 2 | Legacy asbestos via PI Trust (structurally separate); ordinary commercial otherwise |
| Pension | 1 | Frozen, overfunded |
| Restructuring / one-times | 1 | Modest, well-disclosed |
| Accounting aggressiveness | 1 | Clean policies, long-tenured auditor |
| **Overall** | **1.2** | **Clean** |

#### Open Questions and Data Gaps

- WAVE JV detailed financials not separately disclosed (equity method) — implicit trust in mgmt definition of adj. EBITDA
- Pension net funded status as of 12/31/2025 not specifically quoted; assumed neutral based on disclosure tone
- Asbestos Trust's residual AWI ownership not quoted publicly (it has divested over time)
- SBC trending higher (1.4% revenue) — worth tracking; not yet at concerning level

#### Next-Step Dependencies

- Step 05 quarterly momentum view will use the cash conversion as a quality factor
- Step 06 balance sheet will detail debt structure and pension
- Step 09 ROIC computation will use clean NOPAT (no QoE adjustments needed)
- Step 14 valuation in `/complete-coverage` will apply no QoE discount — multiple at full

#### Source Index

| Tag | Document / URL | Section | Date | Notes |
|-----|----------------|---------|------|-------|
| [S1] | AWI 10-K FY2025 | Audit opinion + risk factors + notes | 2026-02-24 | Local: `AWI_financials/sec_filings/10K_FY2025_summary.md` |
| [S2] | https://en.wikipedia.org/wiki/Armstrong_World_Industries | History + trust | 2026-05-28 | — |
| [S3] | NYSE short interest report | Float | 2026-05-15 | — |
| [S4] | SEC EDGAR XBRL companyfacts | Multi-year financials | 2026-05-28 | Local: `AWI_financials/xbrl/xbrl_summary.md` |
| [S5] | AWI 8-K Q1 2026 release | Adj. EBITDA definition | 2026-04-28 | Local: `AWI_financials/other/consensus.md` |
| [S6] | https://www.pymnts.com/cpi-posts/eu-ec-approves-acquisition-of-armstrongs-ceilings-business-by-knauf/ | Divestiture context | 2018 | — |
| [S7] | Fintel / S&P Capital IQ | Short interest data | 2026-05-15 | — |

## Deeper Financial Analysis

The fundamental tier ($1.00) adds 8 dimensions not included here:

- Revenue Breakdown — segment revenue, geographic mix, product-line margins
- Financial Trends — QoQ momentum, leading indicators, inflection points
- Balance Sheet — debt structure, dilution risk, working capital dynamics
- Capital Allocation — ROIC, buyback cadence, reinvestment efficiency
- Earnings Analysis — beats/misses, guidance vs actuals, transcript highlights
- Competitive Positioning — market share, pricing power, peer benchmarks
- Industry Context — TAM, sector tailwinds/headwinds, regulatory backdrop

**API endpoint:** GET /api/v1/research/AWI/fundamental

## Navigation

- Overview: /stocks/AWI
- Financials (this page): /stocks/AWI/financials
- Thesis: /stocks/AWI/thesis
- Investment Memo: /stocks/AWI/memo
- Coverage universe: /stocks